article thumbnail

Warren Buffett's Flashing Warning Sign for Wall Street: He's Being Fearful While Other Investors Are Greedy

The Motley Fool

And what is the legendary investor thinking these days? However, the 94-year-old investor's actions speak louder than his words. Perhaps the most compelling reason to believe that Buffett is fearful now, though, is that many other investors appear to be greedy. I'd prefer to say that investors probably should be cautious.

Investors 246
article thumbnail

Here's Billionaire Investor Bill Ackman's Favorite Artificial Intelligence (AI) Stock -- and Why It's a No-Brainer Buy for 2025

The Motley Fool

Google Cloud should have tremendous growth prospects as more organizations migrate to the cloud over the next decade, with AI accelerating this shift. However, I believe the stock remains a great pick for long-term investors. Unsurprisingly, Google Cloud's business is booming. In Q3, the unit's revenue jumped 35% year over year to $11.4

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Better Artificial Intelligence (AI) Stock: Nvidia vs. Micron Technology

The Motley Fool

In this article, we will take a closer look at the prospects and the valuation of both companies to find out which one of these two is the better AI stock to buy right now. The good news for Nvidia investors is that the demand for AI GPUs remains robust. The company sold an estimated 3.76 Should you invest $1,000 in Nvidia right now?

Prospects 246
article thumbnail

This Unstoppable Biotech Stock Just Became an Even Better Buy

The Motley Fool

Now, Summit has recently made a move that could pay even more significant dividends down the road and improve its prospects. Let's see what that could mean for Summit Therapeutics' prospects. Investors should get in before ivonescimab-related success sends its share price even higher. Summit's market capitalization of $15.3

Prospects 227
article thumbnail

C3.ai's CEO Says This May Have Been the "Most Significant Event in the Company's History"

The Motley Fool

Growth investors are often willing to look past a company's underwhelming bottom line if they're convinced that the business has a promising future and path forward. Investors are bullish on its long-term prospects, given the company's varied AI services, which can attract customers from many different industries.

Companies 246
article thumbnail

2 High-Yield Dividend Stocks That Are Bargain Buys Right Now

The Motley Fool

Pfizer looks attractive at these levels, considering its prospects. Long-term, income-oriented investors should consider scooping up its shares while they remain down. And in the long run, patent cliffs won't sink its prospects. Pfizer's forward price-to-earnings (P/E) ratio of 8.9 They haven't before.

Prospects 221
article thumbnail

Billionaire Investor Warren Buffett Sold Apple Shares for a Fourth Straight Quarter. Should Investors Be Worried?

The Motley Fool

Apple no longer accounts for close to half of Berkshire Hathaway 's portfolio, as the billionaire investor has been unloading shares of the company for multiple quarters -- the streak has now hit four consecutive periods. Is this bad news for Apple investors? That's more than the $277 billion it reported just a few months earlier.

Investors 246